| Tag | Content |
|---|
EnhancerAtlas ID | HS176-17025 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr17:62690210-62691280 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr17:62691020-62691041 | AAAAAAAAAGAAAAAGAAAAA | - | 6.09 | | KLF16 | MA0741.1 | chr17:62690744-62690755 | GGGGGCGGGGC | - | 6.02 | | KLF5 | MA0599.1 | chr17:62690745-62690755 | GGGGCGGGGC | - | 6.02 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_30417 | chr17:62690032-62690761 | Fetal_Muscle | | SE_34286 | chr17:62689033-62691526 | HCT-116 | | SE_37999 | chr17:62689432-62691244 | HUVEC | | SE_45744 | chr17:62689847-62691480 | Osteoblasts | | SE_55875 | chr17:62689368-62691638 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I064693 | chr17 | 62689594 | 62691320 |
|
Enhancer Sequence | GCAGGATCCC TAAATGAAGC AGATAAAGAC GTGATTTGCA AGTAGCAATG ACACCTTCAT 60
ACTGGTCCTA ATGGTAGAGG GGTTCCCTAA CTCAACACTG CCCCGTTCCT GTGGTCAGAG 120
CACCTCTCTC TGATGTCGTC AGGAACAACC CCAGGCCAAA TTCAAGTGAG AAAACTGGAG 180
CTTAACAGTG GTTCCTAGGG TTAGTTGGAT CCAAAGAATC AATTGCTAAA GTAGAAGTTG 240
AGGGAGGTGT GAGTCAAGAA CAGCCTCTGT GGAAATGACT TCAGGCTTTT AGTTGACAAT 300
GGGCTCGGTG TGAGTCATTC TAGGGACATG GGCTCTTGGC CAAAGAATTG CACTGAGGAT 360
CAAGGACATG ATGGTGACCT GCTGCCAGCA GCCCAGCAGC CTACGCCATA AGCAATACTT 420
TCAGTTCTGG GTGCTTTACT GTAAATGGGA CAAGGAGGAG AGGAATTAAA GTGCTTAGGG 480
ACTTCGAGTC ATGTACCGCA AGCAATGTTT GGAGAAGCTG AGAAAGAAAA CTCAGGGGGC 540
GGGGCGCGGT GGCTCACGCC TGTAATCCCA GCACTTTGGG AGGCTTTGGT GGGCAGATTG 600
CTTGAGGCTG GGAGTTTGAG ACCACCCTGG CCAACATGGC GAAACCCCAT CTCTACTAAA 660
AAATACAAAA ATTAGCCAGG ATCATGGAGG TGCACGCCTG TAATCCCAGC TACTAGGGAG 720
GCTGAGGCAC AAGAATCGCT TGAACCTGGG AGCCAAGATT GCGCCATTGC ACTCCCGCCT 780
GGGTGACAGA GCAAGATGCT GTCTCAAAAA AAAAAAAAAG AAAAAGAAAA AAGAAAAAGA 840
AAAGAAAACT CAGGGGACAC TAACAGCTAG CTGCCTTAAC ATACCTGATA AGCTATCAAG 900
TTCAGGTCAA TTAAATTTGT TCCATGTGGT TCTACAGGAA GTAGCCAGGA CCAGTGTGGT 960
GGGGCTGTAA TTGGAATTAT ACTGAGACAG ACCTTGAGAT AGGAGAACAG ATTTTTGAGT 1020
AGTTTGAAAT GGCAGAAGAT ACATTGGTCT TGAACCTGCT CCTCAAAGTG 1070
|
